न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - phenobarbital 15mg;  ;  ;  ;   - tablet - 15 mg - active: phenobarbital 15mg         excipient: lactose monohydrate magnesium stearate purified talc wheat starch - phenobarbitone is indicated for use as preoperative medication to help reduce anxiety and facilitate induction of anaesthesia. phenobarbitone a long acting barbiturate is indicated as long term anticonvulsant therapy for the treatment of generalised tonic-clonic and simple partial (cortical focus) seizures. seizures (prophylaxis and treatment) of febrile seizures.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - phenobarbital 30mg;  ;  ;  ;   - tablet - 30 mg - active: phenobarbital 30mg         excipient: lactose monohydrate magnesium stearate purified talc wheat starch - phenobarbitone is indicated for use as preoperative medication to help reduce anxiety and facilitate induction of anaesthesia. phenobarbitone a long acting barbiturate is indicated as long term anticonvulsant therapy for the treatment of generalised tonic-clonic and simple partial (cortical focus) seizures. seizures (prophylaxis and treatment) of febrile seizures.

कनाडा - अंग्रेज़ी - Health Canada

pendopharm division of pharmascience inc - phenobarbital - tablet - 15mg - phenobarbital 15mg - barbiturates

कनाडा - अंग्रेज़ी - Health Canada

pendopharm division of pharmascience inc - phenobarbital - tablet - 30mg - phenobarbital 30mg - barbiturates

कनाडा - अंग्रेज़ी - Health Canada

pendopharm division of pharmascience inc - phenobarbital - tablet - 60mg - phenobarbital 60mg - barbiturates

कनाडा - अंग्रेज़ी - Health Canada

pendopharm division of pharmascience inc - phenobarbital - tablet - 100mg - phenobarbital 100mg - barbiturates

कनाडा - अंग्रेज़ी - Health Canada

pendopharm division of pharmascience inc - phenobarbital - solution - 5mg - phenobarbital 5mg - barbiturates

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

eci pharmaceuticals, llc - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - - sedative - anticonvulsant – for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. controlled substance – phenobarbital is a schedule iv drug. dependence – barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree of physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the same level of intox

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

remedyrepack inc. - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - - sedative - anticonvulsant – for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. controlled substance – phenobarbital is a schedule iv drug. dependence – barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree of physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the same level of intox

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

lohxa - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - a. sedative b. anticonvulsant- for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. phenobarbital is a schedule iv drug. barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administrations in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree to physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fa